Response of Human Epidermal Growth Factor Receptor 2-Expressing Prostate Cancer to Trastuzumab Deruxtecan.

Autor: Lap CJ; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, and Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., Rajendran R; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC., Martin JM; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC., Uppal M; The George Washington University School of Medicine, Washington, DC., Escobar A; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC., Heiraty AM; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC., Estephan F; The George Washington University School of Medicine, Washington, DC., Hahn W; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC., Subrahmanyam R; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, Washington, DC., Nava VE; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, and The George Washington University School of Medicine, Washington, DC., Jain M; The Edward P. Evans Precision Oncology Center of Excellence, Washington DC VA Medical Center, and The George Washington University School of Medicine, Washington, DC.

Publikováno v: Annals of internal medicine [Ann Intern Med] 2024 Nov 05. Date of Electronic Publication: 2024 Nov 05.